Griseofulvin 330 mg Oral Tablet
RxNorm 245249
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 245249 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: griseofulvin 330 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Griseofulvin 330 mg Oral Tablet
(Atom ID: 12337085)
PSN
Prescribable Name (PSN):
Griseofulvin 330 mg Oral Tablet
(Atom ID: 6358897)
PT
Designated preferred name (PT):
Griseofulvin 330 mg oral tablet
(Atom ID: 9250888)
PT
Designated preferred name (PT):
Griseofulvin ultramicrosize 330 mg oral tablet
(Atom ID: 9250897)
FN
Full form of descriptor (FN):
Product containing precisely griseofulvin 330 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10313151)
FN
Full form of descriptor (FN):
Product containing precisely griseofulvin ultramicrosize 330 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10313167)
Patient Education
Griseofulvin
Griseofulvin is used to treat skin infections such as jock itch, athlete's foot, and ringworm; and fungal infections of the scalp, fingernails, and toenails. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.